Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins
1998

Plasminogen Binding in Metastatic Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): M Ranson, NM Andronicos, MJ O'Mullane, MS Baker

Primary Institution: University of Wollongong

Hypothesis

The study aims to characterize the cell-surface plasminogen binding events in three human breast cancer cell lines.

Conclusion

The metastatic MDA-MB-231 cells have a significantly higher capacity to bind plasminogen compared to the non-metastatic MCF-7 and T-47D cells.

Supporting Evidence

  • The MDA-MB-231 cells bound significantly more plasminogen than MCF-7 or T-47D cells.
  • Non-viable cells bound two orders of magnitude more plasminogen than viable cells.
  • Distinct plasminogen binding proteins were detected in the plasma membranes of the cell lines.

Takeaway

This study found that some breast cancer cells can grab onto a protein called plasminogen better than others, which might help them spread in the body.

Methodology

The study used dual-colour fluorescence flow cytometry, ligand histochemistry, and fluorimetry to analyze plasminogen binding in breast cancer cell lines.

Limitations

The presence of non-viable cells may affect the evaluation of authentic cell-surface plasminogen binding capacity.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication